Toxoplasmosis and chorioretinitis in Nigeria.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D002825:Chorioretinitis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009549:Nigeria; D011239:Prednisolone / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D012698:Serologic Tests; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use; D014126:Toxoplasmosis, Ocular / Q000150:complications* / Q000175:diagnosis
D011239:Prednisolone; D013421:Sulfamethoxypyridazine; D011739:Pyrimethamine